Terug
32
Dagbereik
€ 25,90
€ 27,00
52-Weeksbereik
€ 8,61
€ 37,77
Volume
231.649
50D / 200D Gem.
€ 28,74
/
€ 19,64
Vorige Slotkoers
€ 26,52
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 31,6 | 0,3 |
| P/B | 2,8 | 2,9 |
| ROE % | 8,8 | 3,7 |
| Net Margin % | 5,8 | 3,8 |
| Rev Growth 5Y % | 12,2 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 38,75
+44.3%
Low: € 35,00
High: € 42,00
Forward K/W
23,2
Forward WPA
€ 1,14
WPA Groei (sch.)
+0,0%
Omzet Sch.
360 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 1,45
€ 1,42 – € 1,51
|
390 M | 3 |
| FY2026 |
€ 1,14
€ 1,11 – € 1,17
|
360 M | 3 |
Belangrijkste Punten
Revenue grew 12,18% annually over 5 years — strong growth
Debt/Equity of 0,07 — conservative balance sheet
Generating 40,43M in free cash flow
P/E of 31,58 — premium valuation
Cash machine — converts 211,84% of earnings into free cash flow
Capital efficient — spends only 0,72% of revenue on capex
Groei
Revenue Growth (5Y)
12,18%
Revenue (1Y)12,47%
Earnings (1Y)12,54%
FCF Growth (3Y)10,07%
Kwaliteit
Return on Equity
8,77%
ROIC9,35%
Net Margin5,79%
Op. Margin8,89%
Veiligheid
Debt / Equity
0,07
Current Ratio4,03
Interest Coverage28,21
Waardering
P/E Ratio
31,58
P/B Ratio2,75
EV/EBITDA18,28
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,47% | Revenue Growth (3Y) | 9,58% |
| Earnings Growth (1Y) | 12,54% | Earnings Growth (3Y) | -18,19% |
| Revenue Growth (5Y) | 12,18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 329,52M | Net Income (TTM) | 19,09M |
| ROE | 8,77% | ROA | 6,97% |
| Gross Margin | 75,17% | Operating Margin | 8,89% |
| Net Margin | 5,79% | Free Cash Flow (TTM) | 40,43M |
| ROIC | 9,35% | FCF Growth (3Y) | 10,07% |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 4,03 |
| Interest Coverage | 28,21 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 31,58 | P/B Ratio | 2,75 |
| P/S Ratio | 1,83 | PEG Ratio | 2,06 |
| EV/EBITDA | 18,28 | Dividend Yield | 0,00% |
| Market Cap | 602,71M | Enterprise Value | 535,22M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 329,52M | 292,98M | 274,42M | 246,79M | 208,06M |
| Net Income | 19,09M | 16,96M | 28,52M | -17,87M | -11,81M |
| EPS (Diluted) | 0,82 | 0,70 | 1,23 | -0,89 | -0,60 |
| Gross Profit | 247,70M | 216,69M | 195,13M | 175,98M | 148,21M |
| Operating Income | 29,28M | 22,18M | 18,04M | -12,76M | -1,76M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 273,94M | 297,92M | 281,44M | 255,00M | 244,27M |
| Total Liabilities | 55,04M | 81,33M | 87,80M | 133,60M | 116,04M |
| Shareholders' Equity | 218,90M | 216,60M | 193,64M | 121,40M | 128,23M |
| Total Debt | 15,96M | 45,11M | 50,38M | 72,23M | 80,61M |
| Cash & Equivalents | 83,45M | 94,37M | 61,03M | 21,93M | 28,23M |
| Current Assets | 165,17M | 177,56M | 145,29M | 119,76M | 113,55M |
| Current Liabilities | 40,96M | 40,70M | 41,06M | 64,33M | 34,46M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#782 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026